Bicarbonate

Bicarbonate

SCHEMBL9519696

C/C=C/C=C(\CCCCC)c1cccc(F)c1.O=C(O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.40
CES1 P23141 3/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
TBXAS1 P24557 2/20 0.38
PARP1 P09874 1/20 0.38
LTB4R2 Q9NPC1 1/20 0.36
GPR52 Q9Y2T5 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
NPC1 O15118 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL9520434 1.00 CES2 (0.40) CES2CES1PTGS1PTGS2TBXAS1
SCHEMBL10399010 0.88 CES2 (0.40) CES2CES1PTGS1PTGS2TBXAS1
SCHEMBL10399158 0.88 CES2 (0.40) CES2CES1PTGS1PTGS2TBXAS1
SCHEMBL10399012 0.88 CES2 (0.40) CES2CES1PTGS1PTGS2TBXAS1
SCHEMBL9519693 0.85 TBXAS1 (0.39) CES2CES1PTGS1PTGS2TBXAS1
SCHEMBL9520428 0.85 TBXAS1 (0.39) CES2CES1PTGS1PTGS2TBXAS1
Bicarbonate SCHEMBL9519493 0.84 HTR7 (0.49) CES2CES1PTGS1PTGS2HDAC1
SCHEMBL9519610 0.83 PTGS1 (0.45) CES2CES1PTGS1PTGS2TBXAS1
SCHEMBL9519613 0.83 PTGS1 (0.45) CES2CES1PTGS1PTGS2TBXAS1
SCHEMBL10398868 0.83 PTGS1 (0.45) CES2CES1PTGS1PTGS2TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299379-B1 PENTADIENAMIDE PAF-ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1993-04-21 EP disclosed
EP-0299379-A1 Pentadienamide PAF-antagonists F. HOFFMANN-LA ROCHE AG (CH) 1989-01-18 EP disclosed